{"bill":{"bill_id":1377502,"change_hash":"81a28cfa7e1c76a0dd1a73a3570dd88a","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/HB8190\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/house-bill\/8190\/all-info","completed":0,"status":1,"status_date":"2020-09-08","progress":[{"date":"2020-09-08","event":1},{"date":"2020-09-08","event":9}],"state":"US","state_id":52,"bill_number":"HB8190","bill_type":"B","bill_type_id":"1","body":"H","body_id":114,"current_body":"H","current_body_id":114,"title":"Biosimilar Insulin Access Act of 2020","description":"To amend the Public Health Service Act to deem any insulin that is determined by the Secretary to be biosimilar to the reference product to be interchangeable with the reference product, and for other purposes.","pending_committee_id":0,"committee":[],"referrals":[{"date":"2020-09-08","committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"}],"history":[{"date":"2020-09-08","action":"Introduced in House","chamber":"H","chamber_id":114,"importance":0},{"date":"2020-09-08","action":"Referred to the House Committee on Energy and Commerce.","chamber":"H","chamber_id":114,"importance":1},{"date":"2020-09-16","action":"Sponsor introductory remarks on measure. (CR H4487)","chamber":"H","chamber_id":114,"importance":0}],"sponsors":[{"people_id":16460,"person_hash":"ntqo7c9d","party_id":"2","state_id":52,"party":"R","role_id":1,"role":"Rep","name":"Glenn Grothman","first_name":"Glenn","middle_name":"","last_name":"Grothman","suffix":"","nickname":"","district":"HD-WI-6","ftm_eid":2927726,"votesmart_id":3493,"opensecrets_id":"N00036409","knowwho_pid":199967,"ballotpedia":"Glenn_Grothman","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":20125,"person_hash":"7akvxmtj","party_id":"1","state_id":52,"party":"D","role_id":1,"role":"Rep","name":"Michael San Nicolas","first_name":"Michael","middle_name":"F. Q.","last_name":"San Nicolas","suffix":"","nickname":"","district":"HD-GU","ftm_eid":0,"votesmart_id":185972,"opensecrets_id":"","knowwho_pid":450531,"ballotpedia":"Michael_F.Q._San_Nicolas","sponsor_type_id":2,"sponsor_order":2,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13604,"subject_name":"Blood and blood diseases"},{"subject_id":13642,"subject_name":"Competition and antitrust"},{"subject_id":13593,"subject_name":"Drug safety, medical device, and laboratory regulation"},{"subject_id":81058,"subject_name":"Drug therapy"},{"subject_id":13214,"subject_name":"Health technology, devices, supplies"},{"subject_id":13614,"subject_name":"Intellectual property"},{"subject_id":13312,"subject_name":"Licensing and registrations"},{"subject_id":13490,"subject_name":"Prescription drugs"}],"texts":[{"doc_id":2208139,"date":"2020-09-11","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/HB8190\/id\/2208139","state_link":"https:\/\/www.congress.gov\/116\/bills\/hr8190\/BILLS-116hr8190ih.pdf","text_size":301028,"text_hash":"0c02cedd80058dc1a5711ef16f261f42"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}